Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2009 1
2010 2
2011 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

4 results
Results by year
Filters applied: . Clear all
Page 1
Systematic validation of predicted microRNAs for cyclin D1.
Jiang Q, Feng MG, Mo YY. Jiang Q, et al. BMC Cancer. 2009 Jun 18;9:194. doi: 10.1186/1471-2407-9-194. BMC Cancer. 2009. PMID: 19538740 Free PMC article.
MicroRNA expression profiles of head and neck squamous cell carcinoma with docetaxel-induced multidrug resistance.
Dai Y, Xie CH, Neis JP, Fan CY, Vural E, Spring PM. Dai Y, et al. Head Neck. 2011 Jun;33(6):786-91. doi: 10.1002/hed.21540. Epub 2010 Nov 29. Head Neck. 2011. PMID: 21560177
Mature microRNA sequence polymorphism in MIR196A2 is associated with risk and prognosis of head and neck cancer.
Christensen BC, Avissar-Whiting M, Ouellet LG, Butler RA, Nelson HH, McClean MD, Marsit CJ, Kelsey KT. Christensen BC, et al. Clin Cancer Res. 2010 Jul 15;16(14):3713-20. doi: 10.1158/1078-0432.CCR-10-0657. Epub 2010 May 25. Clin Cancer Res. 2010. PMID: 20501619 Free PMC article.
High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma.
Hebert C, Norris K, Scheper MA, Nikitakis N, Sauk JJ. Hebert C, et al. Mol Cancer. 2007 Jan 14;6:5. doi: 10.1186/1476-4598-6-5. Mol Cancer. 2007. PMID: 17222355 Free PMC article.